Pacira BioSciences, Inc.
PCRX
$23.00
-$0.18-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 196.00% | -39.40% | -89.79% | 103.79% | -125.66% |
| Total Depreciation and Amortization | -20.18% | 0.77% | 26.36% | -22.53% | 45.83% |
| Total Amortization of Deferred Charges | -33.83% | -33.45% | -33.64% | -20.97% | 10.94% |
| Total Other Non-Cash Items | -45.60% | 126.76% | -100.61% | -68.41% | 32.73% |
| Change in Net Operating Assets | 144.75% | -469.05% | 186.97% | -866.04% | -740.46% |
| Cash from Operations | 378.35% | -27.58% | 31.86% | 12.82% | -77.44% |
| Capital Expenditure | 50.46% | 68.13% | 89.71% | 5.43% | -69.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 97.99% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.81% | 6,036.68% | 1,017.20% | 198.78% | 576.04% |
| Cash from Investing | -81.08% | 175.86% | 5,353.53% | 183.61% | 508.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | -77.75% | -77.81% | -10,786.46% | 98.15% |
| Issuance of Common Stock | 38.88% | -- | 84.37% | -- | 15.03% |
| Repurchase of Common Stock | 91.27% | -29,955.25% | -62,745.45% | -156,303.13% | -118.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.70% | -1,883.90% | -2,542.05% | -8,950.12% | -330.20% |
| Foreign Exchange rate Adjustments | -100.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 264.87% | -308.29% | -64.44% | -13,952.85% | -73.22% |